Searched for
ANTIPSYCHOTIC
Death rate in ICE immigrant detention centers more than doubles under Trump, Reuters analysis findsFifty individuals have died in U.S. immigration detention since January 2025, a rate that has more than doubled since 2009. Concerns are ri...- RPG Life Sciences bets big on API business, eyes GLP-1 entry by August-SeptemberRPG Life Sciences is prioritizing its API business for future growth, planning a significant acquisition to scale operations. The company a...
- Woman felt strange sensation in legs for 6 months, pain was worse at night while lying down. Hyderabad Neurologist reveals what went wrongDR Sudhir Kumar, a Hyderabad-based neurologist at Apollo Hospitals, revealed a case in which a woman experienced strange pain in her legs f...
- Canadians in long-term care prescribed antipsychotics without psychosis diagnosis, says report; check key findingsNew data reveals a concerning trend in Canadian long-term care facilities. Almost twenty-five percent of elderly residents are receiving po...
- Alembic Pharmaceuticals gets USFDA nod for generic antidepressant tabletsAlembic Pharmaceuticals has received final approval from the USFDA for its generic version of Brexpiprazole tablets, used in treating major...
- Lupin launches generic medication in US marketDrug firm Lupin on Tuesday said it has launched a generic anti-psychotic medication in the US market. The company's product, in strengths o...
- Glenmark gets USFDA nod for generic antipsychotic drugThe company has received approval from the United States Food and Drug Administration (USFDA) for Chlorpromazine Hydrochloride tablets USP,...
- Zydus Cadila gets USFDA nod for antipsychotic drugThe group has more than 243 approvals, and so far filed over 330 abbreviated new drug applications (ANDAs) since it started filings in 2003...
- Cadila Healthcare surges on USFDA approval of antipsychotic drugThe scrip touched an intraday high and low of Rs 484.60 and Rs 465.75 respectively, in the first hour of trade.
- Torrent recalls anti-psychotic tablet from US marketTorrent Pharma Inc, a US subsidiary of Ahmedabad-based Torrent Pharma is recalling anti-psychotic drug Olanzapine 10 mg tablets from the US...
- Wockhardt gets tentative USFDA nod for anti-psychotic drugPharmaceutical firm Wockhardt today said it has received tentative approval from US health regulator for its generic version of anti-psycho...
- Zydus Cadila gets USFDA nod for schizophrenia drugThe company got a tentative approval for aripiprazole orally disintegrating tabs in the strengths of 10 mg, 15 mg, 20 mg and 30 mg.
- Price control of patented drugs may hit MNCs like Pfizer, GlaxoSmithKline hard: AnalystsThe government's decision to cap prices of patented drugs may hit the multinational pharma companies like Pfizer, GlaxoSmithKline and Merck...
- AstraZeneca Q3 net profit down 27 per centAstraZeneca PLC has reported a 27 per cent drop in third-quarter profit as it took nearly half a billion dollars in charges for product lia...
- Johnson & Johnson accused of drug kickbacksJohnson & Johnson paid leading US pharmacy group Omnicare to promote its antipsychotic drug Risperdal for elderly patients, the US governme...
- Zydus, Teva end patent disputesAhmedabad-based ZydusCadila and Israeli generic major Teva have settled their patent disputes over active pharmaceutical ingredients (APIs)...
- Aussie nod for Ranbaxy's anti-psychotic drugRanbaxy Laboratories has received the Australian drug regulator’s nod to sell its generic version of drugmaker Janssen-Cilag's anti-schizop...
- Children's disorders increases sales of US pharma cosSales for children of antipsychotic medicines have exploded, fuelled by a 40-fold increase over nine years in the number of children diagno...
- Lupin receives USFDA nod for anti-psychotic drugDomestic pharma company Lupin Ltd on Monday said it has received tentative approval from the US Food and Drug Administration (USFDA) for it...
- Mankind to venture into anti-psychoticsMankind Pharma, which registered the highest growth in the industry over the last one year, is venturing into the Rs 1,000-crore anti-psych...
Load More
